Privium Fund Management B.V. 4 D Molecular Therapeutics, Inc. Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
A detailed history of Privium Fund Management B.V. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Privium Fund Management B.V. holds 121,000 shares of FDMT stock, worth $540,870. This represents 0.15% of its overall portfolio holdings.
Number of Shares
121,000
Previous 98,500
22.84%
Holding current value
$540,870
Previous $1.06 Million
36.75%
% of portfolio
0.15%
Previous 0.27%
Shares
5 transactions
Others Institutions Holding FDMT
# of Institutions
149Shares Held
58.4MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$33 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$22.8 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$21.9 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$19.7 Million4.93% of portfolio
-
Goldman Sachs Group Inc New York, NY4.27MShares$19.1 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $145M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...